Skip to Content
Merck
  • RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development.

RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development.

eLife (2020-10-08)
Renaud Mevel, Ivana Steiner, Susan Mason, Laura Ca Galbraith, Rahima Patel, Muhammad Zh Fadlullah, Imran Ahmad, Hing Y Leung, Pedro Oliveira, Karen Blyth, Esther Baena, Georges Lacaud
ABSTRACT

The characterization of prostate epithelial hierarchy and lineage heterogeneity is critical to understand its regenerative properties and malignancies. Here, we report that the transcription factor RUNX1 marks a specific subpopulation of proximal luminal cells (PLCs), enriched in the periurethral region of the developing and adult mouse prostate, and distinct from the previously identified NKX3.1+ luminal castration-resistant cells. Using scRNA-seq profiling and genetic lineage tracing, we show that RUNX1+ PLCs are unaffected by androgen deprivation, and do not contribute to the regeneration of the distal luminal compartments. Furthermore, we demonstrate that a transcriptionally similar RUNX1+ population emerges at the onset of embryonic prostate specification to populate the proximal region of the ducts. Collectively, our results reveal that RUNX1+ PLCs is an intrinsic castration-resistant and self-sustained lineage that emerges early during prostate development and provide new insights into the lineage relationships of the prostate epithelium.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Dihydrotestosterone-2,3,4-13C3 solution, 0.1 mg/mL in methanol, 99 atom % 13C, 97% (CP)
Sigma-Aldrich
Tamoxifen, ≥99%
Supelco
4-Hydroxytamoxifen, analytical standard, (E) and (Z) isomers (50:50)